Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

Go back to Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
(NASDAQ: IMUX) Delayed: 14.75 --0 (-0%)
Previous Close $14.75    52 Week High
Open $14.75    52 Week Low
Day High $14.75    P/E N/A 
Day Low $14.75    EPS
Volume